Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Characterization of Broad Spectrum Chemokine Inhibitor Effects on Fetal and Neonatal Outcomes
FY 2025-26
Summary
Preterm birth (PTB) is the birth of a baby before 37 weeks of pregnancy and is a leading cause of neonatal mortality. It affects around 10% of pregnancies and is a risk factor for multiple health disorders, including nervous system and reproductive disorders.
Dr. Lye’s laboratory has shown that a new drug called Broad-Spectrum Chemokine Inhibitor (BSCI) can prevent PTB in mice and macaques. Thus, it is important to study the long-term effects of BSCI on surviving offspring. This will help ensure the safety of the drug as a therapeutic to prevent PTB in pregnant women. My research will study any adverse effects of BSCI.
For this project, I will use a mouse model of PTB. Pregnant mice will be treated with BSCI and will receive an injection of an inflammatory protein called interleukin-1A (IL-1A) to induce PTB. The control groups will receive either saline injections or BSCI injections.
The protective effects of BSCI on development of the mouse fetal brain will be studied. Fetal brains will be collected 2 to 24 hours after IL-1A injections and assessed for injury and inflammation. A separate cohort of animals receiving the same treatments will be tested for neonatal reflexes. Two-week-old mice will be sacrificed, and their brains will be analysed for inflammation using biochemical methods. The remaining neonates will undergo behavioural testing in adulthood to assess overall neurodevelopment. We will analyse if male and female mice react differently to BSCI. Lastly, we will mate these mice to examine whether they can reproduce normally.
This study will help us understand the safety of BSCI and its effects on neurodevelopment and reproductive potential. This research can facilitate the acceptance of BSCI as a potential therapeutic for women who are at risk for PTB.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573159
Name
Shankar Sharanya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of Broad Spectrum Chemokine Inhibitor Effects on Fetal and Neonatal Outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Development; Neonatal Health; Neurobehaviour; Neurodevelopment; Neuroinflammation; Perinatal Health; Pregnancy; Preterm Birth; Reproduction; Therapeutics
Abstract
Preterm birth (PTB) is the birth of a baby before 37 weeks of pregnancy and is a leading cause of neonatal mortality. It affects around 10% of pregnancies and is a risk factor for multiple health disorders, including nervous system and reproductive disorders.
Dr. Lye’s laboratory has shown that a new drug called Broad-Spectrum Chemokine Inhibitor (BSCI) can prevent PTB in mice and macaques. Thus, it is important to study the long-term effects of BSCI on surviving offspring. This will help ensure the safety of the drug as a therapeutic to prevent PTB in pregnant women. My research will study any adverse effects of BSCI.
For this project, I will use a mouse model of PTB. Pregnant mice will be treated with BSCI and will receive an injection of an inflammatory protein called interleukin-1A (IL-1A) to induce PTB. The control groups will receive either saline injections or BSCI injections.
The protective effects of BSCI on development of the mouse fetal brain will be studied. Fetal brains will be collected 2 to 24 hours after IL-1A injections and assessed for injury and inflammation. A separate cohort of animals receiving the same treatments will be tested for neonatal reflexes. Two-week-old mice will be sacrificed, and their brains will be analysed for inflammation using biochemical methods. The remaining neonates will undergo behavioural testing in adulthood to assess overall neurodevelopment. We will analyse if male and female mice react differently to BSCI. Lastly, we will mate these mice to examine whether they can reproduce normally.
This study will help us understand the safety of BSCI and its effects on neurodevelopment and reproductive potential. This research can facilitate the acceptance of BSCI as a potential therapeutic for women who are at risk for PTB.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shankar, Sharanya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~